Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1071-1077
Published online before print February 14, 2005, doi: 10.1161/01.CIR.0000156439.55349.AD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/8/1071    most recent
01.CIR.0000156439.55349.ADv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, M.
Right arrow Articles by Chen, Y. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, M.
Right arrow Articles by Chen, Y. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Remodeling
Right arrow Restenosis
Right arrow Cell signalling/signal transduction
Right arrow Smooth muscle proliferation and differentiation
Right arrow Type 2 diabetes
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2005;111:1071-1077.)
© 2005 American Heart Association, Inc.


Vascular Medicine

Rad GTPase Attenuates Vascular Lesion Formation by Inhibition of Vascular Smooth Muscle Cell Migration

Mingui Fu, MD, PhD*; Jifeng Zhang, MS*; Yu-Hua Tseng, PhD; Taixing Cui, MD, PhD; Xiaojun Zhu, MD; Yan Xiao, MD; Yongshan Mou, MD; Hector De Leon, MD, PhD; Mary M.J. Chang, PhD; Yasuo Hamamori, MD, PhD; C. Ronald Kahn, MD; Yuqing E. Chen, MD, PhD

From the Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Ga (M.F., J.Z., T.C., Y.X., Y.M., H.D.L., Y.E.C.); Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Mass (Y.-H.T., C.R.K.); Cardiovascular Research Institute, Peking University Health Science Center, Beijing, China (X.Z.); Center for Comparative Respiratory Biology and Medicine, School of Medicine, University of California, Davis (M.M.J.C.); and Center for Cardiovascular Development, Department of Medicine, Baylor College of Medicine, Houston, Tex (Y.H.). Dr Fu is now at the Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas.

Correspondence to Dr Y.E. Chen, Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA 30310. E-mail echen{at}msm.edu

Received July 13, 2004; revision received October 3, 2004; accepted November 2, 2004.

Background— Rad (Ras associated with diabetes) GTPase is a prototypic member of a new subfamily of Ras-related GTPases with unique structural features, although its physiological role remains largely unknown. In the present study, we characterized the Rad function in vascular smooth muscle cells (VSMCs) and the influence of adenovirus-mediated Rad (Ad-Rad) gene delivery on vascular remodeling after experimental angioplasty.

Methods and Results— We documented for the first time that neointimal formation using balloon-injured rat carotid arteries was associated with a significant increase in Rad expression as determined by immunohistochemistry and quantitative real-time reverse-transcriptase polymerase chain reaction. The levels of Rad expression in VSMCs were highly induced by platelet-derived growth factor and tumor necrosis factor-{alpha}. Morphometric analyses 14 days after injury revealed significantly diminished neointimal formation in the Ad-Rad–treated carotid arteries compared with Ad-GFP or PBS controls, whereas the mutated form of Rad GTPase, which can bind GDP but not GTP, increased neointimal formation. Overexpression of Rad significantly inhibited the attachment and migration of VSMCs. In addition, Rad expression dramatically reduced the formation of focal contacts and stress fibers in VSMCs by blocking the Rho/ROK signaling pathway.

Conclusions— Our data clearly identified Rad GTPase as a novel and critical mediator that inhibits vascular lesion formation. Manipulation of the Rad signaling pathway may provide new therapeutic approaches that will limit vascular pathological remodeling.


Key Words: atherosclerosis • cell movement • cells, vascular smooth muscle • monomeric GTP-binding proteins • restenosis




This article has been cited by other articles:


Home page
CirculationHome page
L. Chang, J. Zhang, Y.-H. Tseng, C.-Q. Xie, J. Ilany, J. C. Bruning, Z. Sun, X. Zhu, T. Cui, K. A. Youker, et al.
Rad GTPase Deficiency Leads to Cardiac Hypertrophy
Circulation, December 18, 2007; 116(25): 2976 - 2983.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Yada, M. Murata, K. Shimoda, S. Yuasa, H. Kawaguchi, M. Ieda, T. Adachi, M. Murata, S. Ogawa, and K. Fukuda
Dominant Negative Suppression of Rad Leads to QT Prolongation and Causes Ventricular Arrhythmias via Modulation of L-type Ca2+ Channels in the Heart
Circ. Res., July 6, 2007; 101(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Villacorta, J. Zhang, M. T. Garcia-Barrio, X.-l. Chen, B. A. Freeman, Y. E. Chen, and T. Cui
Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H770 - H776.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Ilany, P. J. Bilan, S. Kapur, J. S. Caldwell, M.-E. Patti, A. Marette, and C. R. Kahn
Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level
PNAS, March 21, 2006; 103(12): 4481 - 4486.
[Abstract] [Full Text] [PDF]